Quick links

Secure login

Secure file transfer protocol

Register or renew user


Contact us

Trouble logging in? Forgot password? We can help!

philavax@phila.gov

215-685-6784

215-238-6944


Register a clinic

Fill out both forms, then either email or fax them to us at the contact above.

Clinic registration form
Provider agreement form

On behalf of patients

Request or update record
Patient update request

Looking for something else?

PhilaVax program info
Flat file reporting guide
More PhilaVax resources

Protect Children Against Travel-Associated Infections  This blog post was written alongside Dr. Mayssa Abuali, who has served the Philadelphia pediatric community for the past 10 years.  There are several measles outbreaks internationally and 58 measles cases have been reported across 17 jurisdictions the United States in 2024. 93% of...

RSV Season Ends March 31 As the respiratory syncytial virus (RSV) season draws to a close on March 31, we want to remind all healthcare providers of important considerations regarding administering nirsevimab (Beyfortus) and RSV immunization.  End of RSV season: The RSV season officially concludes on March...

PhilaVax Closed to VFC Orders from 3/26 through 4/1 PhilaVax will be temporarily closed to new VFC orders from 12 p.m. on Tuesday, March 26, until 12 p.m. on Monday, April 1, while the vaccine prices are updated for 2024. Any orders entered into PhilaVax IIS during this time will be deleted...

Updated CDC Guidance for Community Settings Earlier this week, the CDC updated the respiratory virus guidance and suggested additional doses of the COVID-19 vaccine for those aged 65 and older.  The recommendations in this guidance may help reduce spread of respiratory illness such as RSV, influenza, and others. People in...

Recommend HPV Vaccine at Every Visit!  The HPV vaccine is approved for ages 9 years through 45 years for all genders. The American Cancer Society and American Academy of Pediatrics (AAP) recommend vaccination at age 9.  Early vaccination at age 9-10 years has several benefits, including more...

Protect Your Patients from Flu, COVID-19, and RSV  There are currently high rates of respiratory illness nationwide, including flu, COVID-19, and RSV. Continue to recommend immunization to prevent severe illness and hospitalization. Below, review eligibility recommendations from the CDC and stay updated on flu products available...

Mpox Vaccine: Presidents' Day Reminder The City of Philadelphia is closed on Monday, February 19, 2024, in observance of Presidents' Day. Be sure to submit your Mpox vaccine requests by Tuesday, February 20, at 5 p.m. to account for the holiday. Regular deliveries resume on Wednesday...

Beyfortus (Nirsevimab) Supply and Borrowing Update The supply of nirsevimab allocated to the Vaccines For Children (VFC) program has been depleted. Therefore, no doses are available to order for the remainder of the 2023-2024 respiratory syncytial virus (RSV) season. As we approach the end of the RSV...

Reminder for Bridge Access Providers Only adults 18 and over who are uninsured or underinsured are eligible to receive a COVID-19 vaccine under the Bridge Access Program (BAP).  Screening an individual for eligibility before giving a BAP COVID-19 dose is a requirement outlined in the provider agreement. Uninsured:...

Lunch & Learn: Injection Safety Best Practices Join us for an informative, virtual session on Friday, February 2, 2024 from 12 to 1 p.m. This session is for outpatient providers. The Immunization Program is partnering with the Healthcare Associated Infections/Antimicrobial Resistance (HAI/AR) Program within the Division of Disease Control for this...